Similarly, RenCa cell-derived exosomes combined with cytokines GM-CSF and IL-12 can significantly enhance specific CD8+ T cell responses, inhibiting tumor growth in animal models (Zhang et al., 2009). The gene discussed is CD8A; the disease is neoplasm.